Anton Balazh / Shutterstock.com
The world’s largest trade agreement was signed yesterday, November 15, but the deal has been dogged by concerns over provisions covering pharma patents, traditional knowledge, and copyright.
The rest of this article is locked for subscribers only. Please login to continue reading.
If you don't have a login, you will need to purchase a subscription to gain access to this article, including all our online content. Please use this link and follow the steps.
For multi-user price options, or to check if your company has an existing subscription to us that we can add you to for FREE, please email Atif Choudhury at firstname.lastname@example.org
Regional Comprehensive Economic Partnership, ASEAN, trade deal, IP enforcement, access to medicines, copyright, MSF Access